Addus HomeCare Corporation ADUS

Addus HomeCare (ADUS) is pursuing rapid scale through a $275 million acquisition of AccentCare’s personal care division, a move expected to add about $280 million in annual revenue. The deal expands Addus into 10 states (Texas, Illinois, California, Arizona, plus Colorado, Georgia, Minnesota, Pennsylvania, Tennessee, Washington) and adds to a base that already includes strong organic growth in personal care (about 6.8% year over year) and faster hospice growth. Financing comes from the revolver and cash, not new equity, and current debt would rise after closing. The AccentCare unit includes roughly 13,700 daily customers; hospice and home health remain outside the deal. In Q2, net service revenues rose 8.0% to $377.4 million, adjusted EBITDA rose 11.9% to $49.2 million, with cash flow from operations of $40 million. Regulators and closing conditions could delay the bolt-on, and future rate increases remain uncertain. The $275 million acquisition adds roughly 20% of revenue and expands footprint, but integration costs and higher leverage create meaningful risk that could materially shape future performance.

Addus HomeCare acquires AccentCare's personal care business, which UBS says likely supports growth. Acquisition represents major strategic move likely to alter Addus trajectory and investor sentiment.

Addus HomeCare acquires AccentCare personal care business to advance M&A strategy. Acquisition advances M&A strategy and expands Addus operations and market reach.

BofA states Addus HomeCare consolidation cannot offset Medicaid funding pressures. Medicaid funding pressures threaten Addus HomeCare profitability despite consolidation.

Addus HomeCare Corporation announces a definitive agreement to acquire the Personal Care Division of AccentCare. Acquisition expands Addus HomeCare operations and market presence through major strategic move.

RBC analysts project Addus HomeCare Q2 momentum will continue. RBC positive outlook on sustained momentum may moderately lift ADUS investor sentiment and near-term stock performance.

Addus HomeCare Corp (ADUS) reported strong revenue growth in its Q2 2026 earnings call highlights. Strong revenue growth in Q2 2026 earnings signals significant positive effects on Addus HomeCare financial trajectory and investor sentiment.

Addus HomeCare Corporation released Q2 earnings call highlights covering financial results, operational metrics, and forward guidance for the home care services provider. Q2 earnings data and outlook statements can moderately shift near-term investor views and valuation multiples for ADUS.

Addus HomeCare beat Q2 2026 earnings estimates while maintaining steady margins with analysis of effects on shareholders. Earnings beat and steady margins signal moderate positive effects on financial performance and investor views.

Addus HomeCare (ADUS) Q2 earnings results include key metrics compared directly to Wall Street estimates. Q2 earnings metric comparisons can shift near-term investor sentiment on ADUS financial performance.

Addus HomeCare Corporation announced its financial results for the second quarter of 2026. Quarterly earnings releases deliver performance metrics that moderately shape near-term investor views and stock movement.

Addus HomeCare Corporation (ADUS) evaluated as one of the best small-cap value stocks to buy after strong Q1 performance. ADUS highlighted as top small-cap value pick post-Q1, likely influencing investor sentiment moderately.

Addus HomeCare Corporation (ADUS) beat Q1 earnings expectations and completed acquisitions in Indiana, prompting a valuation analysis highlighting improved financials and growth prospects. Q1 earnings beat and Indiana acquisitions represent major financial success and strategic expansion boosting ADUS trajectory and investor sentiment.

Addus HomeCare Corporation released Q1 earnings call highlights, covering financial results, revenue growth, operational updates, and forward guidance. Q1 earnings highlights detail financial performance and strategic outlook that significantly impact ADUS stock price and investor sentiment.

Addus HomeCare Corporation released Q1 2026 earnings call summary detailing quarterly financial performance, operational updates, and future outlook. Q1 2026 earnings summary provides critical financial metrics and guidance directly shaping ADUS investor sentiment and stock performance.

Addus HomeCare reported Q1 earnings beat despite revenue miss, alongside new Indiana deals, prompting debate on whether ADUS investors should act. Mixed Q1 earnings beat with revenue miss and Indiana deals moderately affect financial performance and expansion prospects without fundamentally altering long-term trajectory.

Addus HomeCare Corporation (ADUS) Q1 earnings topped analyst estimates. Q1 earnings beat signals strong financial performance and likely boosts stock price and investor sentiment.

Addus HomeCare Corporation (ADUS) Q1 earnings key metrics compared to estimates, highlighting performance against analyst expectations. Q1 earnings metrics versus estimates significantly affect financial performance, investor sentiment, and stock trajectory.

Addus HomeCare Corporation announced first quarter 2026 financial results. Quarterly earnings announcements significantly impact financial performance and investor sentiment.

Addus HomeCare Corporation (NASDAQ:ADUS) missed Q1 CY2026 sales expectations. Q1 sales miss highlights weaker revenue performance, likely impacting short-term financial results and investor sentiment.

Addus HomeCare Corporation (ADUS) released Q1 results, outlining key revenue growth, net income, EBITDA, Medicare/Medicaid trends, and future guidance ahead of its earnings call. Q1 earnings reports with detailed financial metrics and guidance directly influence ADUS stock trajectory and investor confidence.

BTSG highlights industry shift to home care with margins expanding for Addus HomeCare Corporation (ADUS) in 2026. Home care shift and 2026 margin expansion represent major strategic tailwinds altering ADUS trajectory and investor sentiment.

Addus HomeCare outlined 2026 priorities at the KeyBanc Forum, including expansion in personal care and hospice, as Medicaid redeterminations ease, reducing client disruptions and boosting revenue visibility. Easing Medicaid redeterminations removes client loss pressures while 2026 priorities target growth in core segments, significantly enhancing revenue trajectory and investor outlook.

Addus HomeCare ended Q4 strongly and started Q1 solidly despite weather and holiday disruptions. Strong Q4 results and positive Q1 outlook despite headwinds signal significant operational strength, enhancing financial performance and investor sentiment.

Addus HomeCare CFO at conference flags uncertain Medicaid rate outlook, progress on Gentiva deal, and active M&A pipeline. CFO updates on Medicaid rates, Gentiva deal progress, and M&A pipeline indicate major strategic developments affecting revenue and expansion.

Addus HomeCare Corporation (ADUS) delivered a strong fourth-quarter earnings beat, prompting a detailed valuation analysis amid positive market reaction. Strong Q4 earnings beat enhances financial outlook and investor sentiment, significantly impacting future performance.

Addus HomeCare Corp (ADUS) reported strong revenue growth in Q4 2025 earnings call highlights. Strong revenue growth in Q4 2025 positively influences financial performance and investor sentiment.

Addus HomeCare Corporation released Q4 earnings call highlights, covering financial performance, operational updates, and future outlook for the home care provider. Q4 earnings highlights detail financial results and guidance that significantly shape investor expectations and stock performance.

Addus HomeCare Corporation released its Q4 2025 earnings call summary, detailing financial performance, operational updates, and future outlook for the home care services provider. Quarterly earnings summaries often reveal revenue growth, margins, guidance, and strategic shifts that significantly influence ADUS stock trajectory and investor sentiment.

Addus HomeCare (ADUS) Q4 earnings highlight key metrics performance against analyst estimates. Q4 earnings metrics versus estimates significantly shape financial trajectory and investor sentiment.